new non-hormonal SERM (medication) may help vulvovaginal atrophy without increased bc
risk
Reproductive Biology | 25/77 in Obstetrics & GynecologySource:2012 Journal Citation Reports® (Thomson Reuters, 2013) Profile of Ospemifene in the Breast Sarah L. Berga, MD1,2⇑ 1Department of Obstetrics and Gynecology, Wake Forest School of Medicine, Winston–Salem, NC, USA 2Women's Health, Wake Forest Baptist Health, Winston–Salem, NC, USA Sarah L. Berga, Wake Forest Baptist Health, Medical Center Boulevard, Winston–Salem, NC 27157, USA. Email: sberga@wakehealth.edu Abstract Vulvar and vaginal atrophy (VVA) is a chronic, progressive medical condition prevalent among postmenopausal women, which produces symptoms such as dyspareunia, vaginal dryness, and vaginal irritation. Currently, the only prescription options are systemic and vaginal estrogen therapies that may be limited by concerns about long-term safety and breast cancer risk. Ospemifene is a tissue-selective estrogen agonist/antagonist (a selective estrogen receptor modulator) recently approved by the US Food and Drug Administration for treatment of dyspareunia, a symptom of VVA, due to menopause. Ospemifene, the first nonestrogen oral treatment for this indication, may provide an alternative to treatment with estrogen. Animal models with ospemifene suggest an inhibitory effect on growth of malignant breast tissue, but animal data cannot necessarily be extrapolated to humans. Clinical trials, including 3 long-term studies assessing the overall safety of ospemifene, support that ospemifene is generally well tolerated, with beneficial effects on the vagina, neutral effects on the breast, and minimal effects on the endometrium. |
Re: new non-hormonal SERM (medication) may help vulvovaginal atrophy without increase
yippee! They made this for me.
|
Re: new non-hormonal SERM (medication) may help vulvovaginal atrophy without increase
This I need also - seriously quick though - 36 is way too young to be having sexual issues if you ask me!!
|
Re: new non-hormonal SERM (medication) may help vulvovaginal atrophy without increase
Going to ask my doctor about this...I see her on Thursday. This could be HUGE!!!
|
All times are GMT -7. The time now is 05:17 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021